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Abstract: The surgical resection of the epileptogenic zone is the indicated treatment in drug-
resistant focal epilepsy. For this purpose, an accurate localisation of epileptogenic zone is crucial. A
new method combining ictal SPECT and interictal PET is being validated. To this end, we simulated
data, implemented the new methodology and validated it. Results show that the development of an
automatic procedure to evaluate the presented method can be implemented.
I. INTRODUCTION
Epilepsy is an important disease in the world affecting
50 million people with 2.4 million cases being diagnosed
annually [1]. In most patients antiepileptic drugs are ben-
eficial to treat seizures. However, still millions (between
25%-30% of the cases) have drug-resistant epilepsy [2].
This type of epilepsy is known as focal epilepsy and it’s
generally caused by structural brain lesion. Surgery is
the indicated treatment for the resection of the seizure
onset zone in those cases [2].
Surgery intervention requires the exact determination
of the epileptogenic zone (EZ) in the pre-surgical work-
up [3]. Advances in neuroimaging have substantially im-
proved the surgical treatment that we can claim that
epilepsy surgery is successful in 70–80% of operated-on
patients [4]. Several techniques are used for this purpose,
the most relevant being Magnetic Resonance Imaging
(MRI), Electroencephalography (EEG), Single Photon
Emission Computed Tomography (SPECT) and Positron
Emission Tomography (PET).
MRI is a non-invasive high resolution image that pro-
vides structural information of the brain. The identifica-
tion of any type of epileptogenic lesion by MRI leads to
a higher surgery success [4]. Unfortunately, in absence of
an MRI lesion, epilepsy surgery outcomes are markedly
reduced [5].
EEG is the common diagnostic tool for seizure locali-
sation. It consists of electrodes that detect the neurons’
ionic current. It is usually complemented with video
recording to correlate patient’s behaviour with the EEG’s
signals. EEG’s lower sensitivity in respect of other neu-
roimaging techniques has led to a decrease in the use of
invasive EEG [4]. Its spatial limitation means that many
patients are not ultimately candidates for surgery [5].
Both SPECT and PET are nuclear medicine tech-
niques consisting in the use of radiopharmatheutical trac-
ers. Those tracers are bounded to a specific molecule, so
that the radiotracer distribution follows the molecules
behave [6]. On one hand, SPECT technique is based on
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the detection of gamma rays produced in the decay of
the radioactive compound mentioned [6]. On the other
hand, PET technique is based on the detection of pairs of
gamma rays coming from the annihilation of the positron
emitted by the nuclear decay of the radiotracer [6]. The
detection involves effects of noise, attenuation, scattering
and Point Spread Function (PSF) that need to be cor-
rected. Given its nature, PET provides a better signal-to-
noise ratio and a higher spatial resolution than SPECT
images [3, 7].
SPECT and PET have risen to be promising tools in
the presurgical evaluation of patients with focal epilepsy
[2, 5, 7]. The former is unique to map brain perfu-
sion during seizures (ictal state). It consists in 99mTc-
hexamethylpropyleneamine oxime (99mTc-HMPAO) in-
jection either in the ictal or interictal state (24h period
free of seizures). Ictal SPECT shows the increase in re-
gional cerebral perfusion flow in the seizure onset zone
compared to interictal SPECT [3]. The latter consists in
18F-fluorodeoxyglucose (18F-FDG) injection in the inter-
ictal state and shows hypometabolic zones related to the
functional deficit of the ictal onset zone [7].
Qualitative visual analysis of SPECT studies involves
comparison of each cerebral region with its contralateral
side or between ictal and interictal studies. However,
visual comparison can be difficult, because ictal and in-
terictal studies often vary significantly in intensity and
image orientation, being observer dependent. As a con-
sequence, several computer-aided methods have been de-
veloped to overcome these limitations.
Subtraction of Interictal SPECT from ictal SPECT
Coregistered with MRI (SISCOM) is a methodology for
the EZ localisation proposed by O’Brien et al. in 1998 [8].
This methodology combines SPECT functional informa-
tion with the anatomical information that MRI provides.
Functional information comes from a parametric image
that reflects the differences in regional cerebral blood flow
between ictal and interictal studies. O’Brien included the
following steps: 1) SPECT-SPECT registration, 2) inten-
sity normalisation, 3) subtraction and thresholding and
4) coregistration of the thresholded image to MRI [8].
Hospital Cĺınic of Barcelona developed a new software to
implement SISCOM called FocusDET.
SISCOM has demonstrated to be a highly valuable
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diagnostic tool in localisation of the seizure-onset zone
[3, 9]. However, the role of interictal SPECT has been
relegated as a baseline study for ictal SPECT subtrac-
tion due to its lower sensitivity [3, 9]. On the other hand,
PET studies could provide advantageous information not
used in SISCOM analysis due to its better characteristics
[3]. This pretext using PET studies in place of interictal
SPECT images for SISCOM analysis. The new procedure
is named PET Interictal Subtracted from ictal SPECT
Coregistered with MRI (PISCOM) [3].
The European Association of Nuclear Medicine Neu-
roimaging Committee (ENC) provides guidelines for
brain neurotransmission SPECT using 99mTc-HMPAO
and PET using 18F-FDG that include recommendations
on reconstruction methods, filtering and applied data
corrections [10, 11]. According to these guidelines, each
centre chooses its own image processing conditions. In
particular, it is of paramount importance to analize the
influence of the reconstruction parameters on the locali-
sation of the EZ. In this direction, the objectives of this
work are:
• Implementation of a pipeline to automatize the pro-
cessing and validation procedure allowing to vary
and validate different parameters involved in the
image analysis.
• Development of a validation process to objectively
prove the PISCOM technique, without the need of
nuclear medicine physician visual validation.
II. MATERIAL AND METHODS
A. Simulation and reconstruction
The determination of the best EZ localisation requires
a gold standard that allows to evaluate the differences
between the obtained and real localisation. Monte Carlo
simulation allows to reproduce a variety of anatomical
and tracer uptake cases. Thus, Monte Carlo simulation
is used in image processing to generate realistic 99mTc-
HMPAO and 18F-FDG projections from known activity
maps with a known EZ and its corresponding attenuation
map. Since the ground truth is known, this strategy
enables the development of a methodology to optimize
reconstruction parameters.
To undergo PISCOM analysis, MRI, SPECT and PET
images are needed. Firstly, MRI studies corresponding to
40 subjects free of cerebral abnormalities were selected.
Then, these MRI studies were segmented into Grey Mat-
ter (GM), White Matter (WM) and Cerebrospinal Fluid
(CSF) using Statistical Parametric Mapping (SPM) fa-
cilities.
To perform the simulation, activity maps, attenua-
tion map and a theorical focus are needed. The activ-
ity maps (see Fig. 1) were obtained by assigning differ-
ent intensity values to each tissue obtained empirically
(GM=100; WM=25; CSF=4). To generate the attenua-
tion maps, threshold segmentation is used to separate the
computed tomography image into water and bone. Ap-
propriate attenuation coefficients for bone (0.323 cm-1)
and brain (0.155 cm-1) tissue are assigned (see Fig. 1).
Nine theoretical focus were defined (with volumes from
8.6 to 10.4 cm3) by a nuclear medicine physician expert in
brain SPECT and PET analysis in the following regions:
frontal cortex, occipital cortex, parietal cortex, temporal
cortex, hippocampus and amygdala, hippocampus and
parahippocampus, insular cortex and orbitofrontal cor-
tex. One of them is shown in Fig. 1. Moreover, for each
patient, two groups of focus levels were distinguished for
SPECT: low level (ranging from 0 to 0.5) and high level
(ranging from 0.5 to 1) in order to evaluate different de-
grees of hyperperfusion.
FIG. 1: Maps used in simulation. From left to right: saggital
view of attenuation map, axial view of activity map and axial
view of a theoretical focus.
Once having activity maps, attenuation maps and the
theorical focus, 99mTc-HMPAO SPECT and 18F-FDG
PET projections were simulated by SimSET v2.9 Monte
Carlo code considering the Hospital Cĺınic equipment
characteristics. In PET simulation SimSET was config-
ured to obtain sinograms with total counts of around 80
million. The equipment considered was a BGO-based
Siemens Biograph scanner consisting in a cylindrical de-
tector with 32 axial rings of 41.2 cm radius. A 3D-mode
acquisition with no axial compression was simulated us-
ing an energy window of 350-650 keV. Sinogram dimen-
sions were 288 transaxial bins (bin size = 2.2 mm) and
288 angular positions. Photons were separated into true
and scatter coincidences, providing an ideal scatter cor-
rection. Attenuation map and activity map configured
the background image, which was obtained as the inter-
ictal maps.
SPECT simulation was configured to generate emis-
sion projections from four to six million photons using
InfiniaTM HawkeyeTM 4 from GE Healthcare scanner
operating with a 35 mm long parallel collimator (hexag-
onal holes, radius: 0.75 mm, septal thickness: 0.2 mm).
SPECT simulation was performed along 120 projections
over 360o in a 128 × 54 matrix of 3.32 × 3.32 mm2 pixel
size. The simulation considered an energy window of 20%
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centred at 140 keV. Ictal maps were generated from the
background image and a theoretical focus.
Once having the projections, 3D images were ger-
erated through Ordered Subset Expectation Maximiza-
tion (OSEM) reconstruction algorithm. Regarding PET
studies, it was used 12 iterations, 8 subsets, an energy
window of 350 keV for minimun energy in scatter cor-
rection and a gaussian filter of 3.5 mm Full Width at
Half Maximum (FWHM). On the other hand, for SPECT
studies 10 iterations, 10 subsets and ictal attenuation
map were used.
B. PISCOM analysis
The PISCOM method was performed following the
same steps as SISCOM analysis but replacing the inter-
ictal SPECT image with a preprocessed interictal PET
image. 18F-FDG PET images were first degraded to as-
similate features of 99mTc-HMPAO SPECT images as fol-
lows: (1) intensity normalisation was applied to 18F-FDG
PET images to correct for differences in the total number
of photons detected, (2) 18F-FDG PET images were re-
sampled to match ictal SPECT’s matrix and voxel size,
and (3) 18F-FDG PET images were filtered to achieve
similar smoothing between the ictal SPECT and PET
images.
To obtain filtered PET image with a degradation
equivalent to that of SPECT studies it was assumed that
the imaging system is linear. With that assumption,
it can be written f(x, y, z) = h(x′, y′, z′) ⊗ ρ(x′, y′, z′),
where ⊗ means convolution and h(x′, y′, z′) is the PSF
that degrades the real radiotracer’s distribution density
ρ(x′, y′, z′) into the resulting image f(x, y, z).
SPECT and PET equipment’s PSF were experimen-
tally mesured. Then a convolution between PET images
and the inverse PSF of the PET adquisition system fol-
lowed by a convolution with the SPECT’s PSF was ap-





Then, preprocessed PET was realigned to ictal SPECT
with SPM by previously assigning image origin to its cen-
tre of mass. This step ensures PET-SPECT spatial core-
lation for later subtraction.
The images were then coregistered with patient’s MRI,
mapping activity images to its anatomical localisation.
Firstly, an algoritm developed for coregister was applied
on the interictal image and secondly, those transforma-
tions were applied on the ictal image. That way, fun-
cional images kept their realignment.
MRI was masked to remove non-brain area. After that,
the subtraction image of interictal image from the ictal
image was computed for every voxel in the masked MRI
following Eq. 2.
subtraction[i, j, k] =
SPECT [i, j, k]− PET [i, j, k]
PET [i, j, k]
(2)
where i, j, k are the coordinates of PET, SPECT and
subtraction images. Only positive subtraction and
PET [i, j, k] 6= 0 cases were considered.
Finally, a threshold of two Standard Deviation (SD)
over the mean value was applied to the subtraction im-
age. This results in a focus extraction from the subtrac-
tion image that is also coregistered with MRI.
All PISCOM analysis was integrated in a Python
pipeline using different Python’s libraries and external
code calls. This way, the script integrated multiple pro-
cessing platforms in a single automatic procedure that
can be replicated anywhere.
C. Validation
Since the theoretical focus prior to simulation is
known, an objective PISCOM validation process can be
implemented. A Python script compares the fusion im-
age from the PISCOM method with the known theoret-
ical focus. The script binarizes the images and iterates
over all voxels. It identifies the region and volume where
both image’s values are 1 or whether fusion or theoreti-
cal focus images are 0. That way, every coincidence case
is contemplated. It is important to note that the fusion
image from PISCOM analysis will consider a particular
region to be true positive even when another region in
the same scan is false positive; that is why it is crucial
to take all options into consideration.
III. RESULTS
A. Simulation and reconstruction
Simulation and reconstruction processes were per-
formed in a computer cluster. The computational time
needed to simulate and compute projection was 3.58
hours for PET studies, whereas the same tasks for
SPECT was 24.21 hours. The capacity required was 1.36
MB for simulation, 9.45 GB for projection and 8.3 MB for
reconstruction, meaning 9.5 GB used per pacient. Out-
puts from simulated and reconstructed maps are shown
in Figs. 2 and 3 respectively.
FIG. 2: Simulated results. From left to right: PET axial
sinogram and a SPECT projection.
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FIG. 3: Axial section of reconstructed images. From left to
right: high and low level ictal SPECT and interictal PET
studies. Same slice in axial view is shown in Fig. 3 to 6.
B. PISCOM analysis
During PISCOM analysis various images were ob-
tained: the preprocessed PET, the realigned prepro-
cessed PET (Fig. 4B), the ictal SPECT coregistered, the
realigned preprocessed PET coregistered and the sub-
traction image coregistered (Fig. 5A). The final out-
put image from PISCOM method was the fusion image,
which is the two SD thresholded subtraction image coreg-
istered to MRI (Fig. 5B).
FIG. 4: Axial view of realigned emission images used in PIS-
COM analysis. Ictal SPECT level high (A) and preprocessed
PET (B).
C. Validation
The validation script extracted the number and coor-
dinates of coincident and non-coincident voxels as well as
FIG. 5: Axial view for high level subtraction image (A) and
fusion image (B) coregisted with MRI.
the resulting images. It considered all types of regions:
where both are coincident, where only fusion image coin-
cides and where only theoretical focus coincides. Finally,
results were summarized in 3 items: volume coincident,
% coincident and % non-coincident. Volume coincident
refers to the coincident volume between fusion image and
theoretical focus. The percentual value coincident is ref-
ered to the whole theorical focus volume. The percentual
value non-coincident refers to the fusion image percentual
volume that isn’t explained by the theoretical focus. Fig.
6 shows coregistered fusion image together with the the-
oretical focus, whereas Tab. I shows some of the results.
FIG. 6: Axial section of the fusion image from PISCOM anal-
ysis and the theoretical focus coregistered with MRI.
IV. DISCUSSION AND CONCLUSIONS
The results of PISCOM analysis (Table I) showed some
(2) patients with fairly good (above 70%) of the theoret-
ical focus explaining the fusion image in contrast with 4
patients presenting poor percentage of the theoretical fo-
cus explaining the fusion image. Nonetheless, all patients
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TABLE I: Coinciding values between fusion image and theo-
retical focus for some of the patients and for each modality.
Patient Volume coincident % coincident % non-coincident
03 Low 7.1 cm3 71.21% 98.37%
03 High 7.1 cm3 71.21% 98.37%
04 Low 5.3 cm3 70.56% 98.73%
04 High 5.5 cm3 72.60% 98.72%
05 Low 1.5 cm3 12.12% 99.63%
05 High 1.6 cm3 12.34% 99.62%
12 Low 0.0 cm3 0.00% 100.00%
12 High 0.0 cm3 0.00% 100.00%
21 Low 1.6 cm3 22.98% 99.64%
21 High 1.6 cm3 22.98% 99.64%
36 Low 0.6 cm3 6.14% 99.87%
36 High 0.6 cm3 6.14% 99.87%
had a large amount of volume that indicated false posi-
tives zones (above 98 % of fusion image volume). Lastly,
no big differences were observed between high and low
level’s SPECT.
The goal of neuroimaging studies in epilepsy is the lo-
calisation of a single EZ objectively and unambiguously
for epilepsy surgery. The majority epilepsy neuroimaging
studies are visually analyzed [2], also taking into account
retrospective nature studies. This has many drawbacks,
the most dodgy being the neurologist subjectivity but
also the lack of quantitative assessment, among others
[2]. This complicates the development of a validated im-
age processing method for EZ localisation. However, the
present work demonstrates that an objective simulation-
based method can be achieved in order to prove whether
image processing techinques lead to a successful EZ lo-
calisation.
V. FURTHER WORK
The present work lead to a further study to complete
the validation of the PISCOM method. For this reason,
a larger database of patients and reconstruction param-
eters variations is needed. Our proposals are:
1. To validate the impact of the reconstruction param-
eters. For the moment, OSEM with a single set of
iterations and subsets was used. In the future we
would like to study how these values can affect the
EZ localisation in PISCOM.
2. To improve the obtained filter for PET preprocess-
ing. Despite in this work the PSF was obtained
experimentally, the aim is to have a simulated PSF.
3. To verify the influence of the z-score used in fusion
threshold as it directly affects the output volume
pointed.
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